Table 3.

Daily concomitant medication costs for ITT, mean (SE)

Daily concomitant medication costs	Placebo (n = 979)	Qsymia recommended (n = 488)
Baseline ($)	2.47 (0.12)	2.83 (0.17)
Unadjusted mean change 56 weeks with LOCF ($)	0.15** (0.05)	−0.22** (0.07)
Adjusted change with LOCF 56 weeks ($)a	Ref.	−0.34* (0.09)

LOCF last observation carried forward, ITT intention to treat

* p < 0.05, ** p < 0.01

^aANCOVA with change in outcome as the dependent variable and treatment arm, sex, mean-centered baseline weight, and mean-centered baseline outcome as independent variables